Advanced Flower Capital (AFCG) Q3 2026 earnings summary

Executive summary

• Q3 net investment income was $3.536 million, or $0.16 per share; NAV rose to $8.55 from $8.25 at June 30, 2026.

• Net increase in net assets from operations was $6.4 million, or $0.28 per share, including $2.9 million of net unrealized gains after taxes.

• Portfolio fair value was $289.6 million across 18 first-lien investments; three loans were on nonaccrual, representing 23.5% of fair value.

Financial highlights

• Q3 total investment income was $8.565 million and NII was $3.536 million, versus $8.692 million and $3.481 million, respectively, in Q2.

• Total assets were $395.1 million and net assets were $191.6 million at September 30; NAV per share was $8.55.

• Net unrealized gains on investments, net of taxes, were $2.864 million; net increase in net assets from operations was $6.400 million.

• Nine-month NII was $11.8 million and net increase in net assets from operations was $23.2 million; comparisons with prior periods are affected by the BDC conversion and accounting change.

• Q3 distribution declared was $0.05 per share, totaling $1.120 million.

Outlook and guidance

• A ~$1.1 billion pipeline spans multiple industries; a near-term expected close was a $43 million senior secured healthcare services facility, with a portion expected to be committed.

• Deployment may be lumpy; underwriting remains selective, prioritizing lender protections, capital preservation and risk-adjusted returns.

• Strategy targets low-double-digit risk-adjusted returns through selectively originated debt with meaningful collateral, high interest coverage and favorable pricing.

• Cash, borrowing capacity and operating cash flows were expected to cover operating requirements and contractual obligations, including the 2027 Senior Notes maturity, for at least 12 months; refinancing options were under exploration.